On the other hand, a high dose of the ATP-competitive dual mTOR and PI3K inhibitor BEZ235 blocks both the S6K1 and 4EBP1 effector pathway and robustly affects cell proliferation with the induction of cell death in certain tumor models [11], [23]. Here, RPS6KB1 is linked to neoplasm.